March 09, 2023 — 10:12 am EST

      Written by
                        RTTNews.com for                             
        




RTTNews ->


(RTTNews) - Novartis AG's (NVS) generics-and-biosimilars division Sandoz signed a Memorandum of Understanding to build a new biologics production plant in Lendava, Slovenia.
Sandoz said it plans to invest at least $400 million in the plant, supporting the company's ambition to drive the future growth of its global biosimilars portfolio.
Work on the new plant is set to begin this year, with full operations provisonally planned for late 2026. 
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

© 2023, Nasdaq, Inc. All Rights Reserved.










To add symbols:


These symbols will be available throughout the site during your session.
To add symbols:


These symbols will be available throughout the site during your session.